Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA approves prostate treatment device

This article was originally published in Clinica

Executive Summary

The US FDA last week approved EDAP Technomed Prostatron, a device that uses microwaves to heat and destroy excess prostate tissue. The new device uses a computer-controlled system to target the prostate gland with microwave heat therapy. The procedure takes one hour and can be done on an outpatient basis with local anaesthesia.

You may also be interested in...



Sawai’s Recent US Launches Outperform Expectations

Sawai’s sales increased on the back of a good performance from recently-launched products in the first nine months of its financial year. However, given the competitive environment the Japanese company is continuing to stick to its full-year forecasts.

OTC Marketing Awards Just Two Weeks Away

This year's OTC Marketing Awards is celebrating innovation and creativity in the British consumer healthcare industry.

US FDA Pharmaceutical Quality Office Lauds Continuous Manufacturing Approvals

The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.

Topics

UsernamePublicRestriction

Register

MT088031

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel